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Membrane bound IgE: the key receptor to restrict high IgE levels
Abstract
The membrane form of immunoglobulins (mIg) is expressed on the surface of B lymphocytes from a
very early developmental stage in the bone marrow (pre B cell) until the cell finally differentiates into a
plasma cell. mIgs associate with other transmembrane proteins to form the B cell antigen receptor
complex (BCR). Numerous studies have confirmed that signaling through the BCR not only steers the B
cell through development, but also ensures its survival in the periphery as a fully matured cell. During
development in the bone marrow, mIg is restricted to the IgM isotype, but as soon as the B cell leaves
the bone marrow to populate peripheral lymphoid organs like spleen, lymph nodes, or intestinal mucosal
tissue, it starts to express IgD and in later stages of maturation IgG, IgE and IgA. Engagement of the B
cell receptor triggers signals that control affinity maturation, memory induction, differentiation and
other physiological processes in B cells. We showed that truncation of the cytoplasmic tail of mIgE in
vivo results in lower serum IgE levels, decreased numbers of IgE-secreting plasma cells, and abrogation
of specific secondary responses correlating with a defect in the selection of high-affinity antibodies
during the germinal centre reaction. We conclude that the BCR is necessary at all times during antibody
responses not only for the maturation process, but also for the expansion of antigen specific B cells. As a
result of these findings it is obvious that the IgE antigen receptor could be a useful target molecule for
therapeutic intervention.
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Abstract: The membrane form of immunoglobulins (mIg) is expressed on the surface of B lymphocytes from a very early 
developmental stage in the bone marrow (pre B cell) until the cell finally differentiates into a plasma cell. mIgs associate 
with other transmembrane proteins to form the B cell antigen receptor complex (BCR). Numerous studies have confirmed 
that signaling through the BCR not only steers the B cell through development, but also ensures its survival in the periph-
ery as a fully matured cell. During development in the bone marrow, mIg is restricted to the IgM isotype, but as soon as 
the B cell leaves the bone marrow to populate peripheral lymphoid organs like spleen, lymph nodes, or intestinal mucosal 
tissue, it starts to express IgD and in later stages of maturation IgG, IgE and IgA. Engagement of the B cell receptor trig-
gers signals that control affinity maturation, memory induction, differentiation and other physiological processes in B 
cells. We showed that truncation of the cytoplasmic tail of mIgE in vivo results in lower serum IgE levels, decreased 
numbers of IgE-secreting plasma cells, and abrogation of specific secondary responses correlating with a defect in the se-
lection of high-affinity antibodies during the germinal centre reaction. We conclude that the BCR is necessary at all times 
during antibody responses not only for the maturation process, but also for the expansion of antigen specific B cells. As a 
result of these findings it is obvious that the IgE antigen receptor could be a useful target molecule for therapeutic inter-
vention. 
INTRODUCTION 
 Compared with the other immunoglobulin classes, which 
are present in serum in concentrations of up to milligrams 
per millilitre, the titre of IgE in the nano- to microgram/ml 
range is very low in the plasma of normal healthy individuals 
and laboratory mouse strains. Beside in plasma, IgE is found 
in epitheliae and mucosae where it is bound to specific re-
ceptors on potent effector cells like eosinophilic granulo-
cytes and mast cells. Cell bound IgE has a long half-life time 
(weeks to months), compared to the short half-live of free 
plasma IgE (~6 hrs.), suggesting that IgE plays a role in local 
immune reactions. Although the biological function of IgE is 
still a matter of speculations, to date IgE is best known for its 
strong, unwanted effector functions manifesting in allergic 
symptoms [1]. These can range from harmless local symp-
toms like hay fever, to life-threatening systemic reactions 
culminating in anaphylactic shocks, underlining the potential 
hazard of high systemic IgE titres. In the recent past several 
B-cell specific control mechanisms indicating a tight control 
of the IgE response have been described. Beside the reduced 
IL-4 dependent class switch recombination to the IgE locus 
[2], the short half life time of free IgE in serum [3], and the 
negative feed-back function of CD23, the "low" affinity re-
ceptor for IgE [4], the key regulator which finally decides 
about the quantity and quality of the IgE antibodies produced 
during an immune response is the IgE antigen receptor itself 
[5-7]. These observations indicate possible mechanisms to  
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restrain potentially dangerous but apparently necessary IgE 
responses occurring at many different levels during the B 
cell differentiation process. Here we want to address the bio-
logical function of the B cell receptor in general, of the mIgE 
antigen receptor in particular, and the therewith connected 
regulatory function on the IgE production. 
THE B CELL ANTIGEN RECEPTOR AND ITS 
FUNCTION DURING B CELL DEVELOPMENT 
 Diversification of the antibody repertoire starts with the 
largely random recombination of V, D and J segments on the 
heavy chain locus and V and J segments on the light chain 
locus. These recombination events result in the random gen-
eration of functional Ig genes and their subsequent transcrip-
tion and translation in the pre-B cell stage of development. 
Finally, the mature, fully recombined mIg protein consists of 
at least 2 light chains and 2 heavy chains followed by the 
mIg transmembrane segments, which are about 25 amino 
acids long [8], and by the cytoplasmic domains which differ 
in length. They range from only three amino acid residues 
(KVK) in the case of mIgM and mIgD to 14 -28 residues for 
the other mIg subclasses. The cytoplasmic tail of human and 
mouse IgE is less conserved when compared to the other Ig 
classes (Fig. 1). In its membrane-bound form mIgs are obli-
gatorily associated with two other membrane proteins, 
CD79-a and CD79–b (Ig- and Ig-, respectively [9]). These 
proteins not only function as a chaperone to facilitate mem-
brane expression but they also couple the antigen receptor to 
membrane-proximal signaling elements. Numerous studies 
have confirmed that signaling through the BCR not only 
steers the B cell through development, but also secures its 
survival in the periphery as a fully matured cell (reviewed in 
[10]). 
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 Summarizing, BCR signaling controls: (a) the expansion 
of only those B cells that have undergone functional V(D)J 
rearrangements during early development; (b) the deletion of 
self-reactive B-cell clones; (c) the survival of B cells by rep-
resenting a maintenance signal in the periphery; (d) upon 
antigen encounter a general activation of the B cell, or, in the 
absence of appropriate co-stimulation, a specific deactiva-
tion, either resulting in apoptosis or in a state called "an-
ergy"; (e) induction of the differentiation into a memory cell; 
and (f) the terminal differentiation into an antibody-secreting 
plasma cell, closely linked with the down regulation of the 
membrane expression of Ig [10]. 
a
 
Fig. (1). (a) Each Ig molecule can be expressed in two isoforms as result of an alternative splicing event. The constant exons for the secreted 
Ig molecule are followed by a poly(A) site for secreted antibody, followed again by exons M1 and M2 coding for transmembrane and cyto-
plasmic domains. The transmembrane form gets polyadenylated by an independent poly(A) site. (b) Sequence alignments of mouse and hu-
man transmembrane and cytoplasmic domains of immunoglobuline different isotypes. The mIg transmembrane segments are about 25 amino 
acids long and have the potential for interaction with other polypeptides. The cytoplasmic domains of mIgs are different in length and range 
from only three amino acid residues (KVK) in the case of mIgM and mIgD to 14-28 residues for the other mIg subclasses. One striking dif-
ference between mouse and man is the existence of two mIgE isoforms in the humans with respect to the extra membrane proximal domain. 
The EMPD region is of critical importance for mobilizing intracellular Ca
2+
, with the EMPD’s length apparently being the ‘sensor’ of 
caspase independent apoptosis sensitivity. 
 
(b) 
mIgM   --------EGEVNAEEEGFENLWTTASTFIVLFLLSLFYSTTVTLFKVK
mIgD   QHSCIMDEQSDSYMDLEEENGLWPTMCTFVALFLLTLLYSGFVTFIKVK
mIgG3  ---ELELNETCAEAQDGELDGLWTTITIFISLFLLSVCYSASVTLFKVKWIFSSVVQVKQTAIPDYRNMIGQGA
mIgG1  ---GLQLDETCAEAQDGELDGLWTTITIFISLFLLSVCYSAAVTLFKVKWIFSSVVELKQTLVPEYKNMIGQAP
mIgG2b ---GLDLDDICAEAKDGELDGLWTTITIFISLFLLSVCYSASVTLFKVKWIFSSVVELKQKISPDYRNMIGQGA
mIgG2a ---GLDLDDVCAEAQDGELDGLWTTITIFISLFLLSVCYSASVTLFKVKWIFSSVVELKQTISPDYRNMIGQGA
mIgE   --ELDLQDLCIEEVEGEELEELWTSICVFITLFLLSVSYGATVTVLKVKWVFSTPMQDTPQTFQDYANILQTRA
mIgA   -------------------SYVLLDQSQDILEAPGASPTVLTALVTTRGPGKEVPQY
Extra Membrane Proximal Domain Transmembrane domain Intracellular tail
hIgM      
hIgD     
hIgG1
hIgG2
hIgG3
hlIgA1
------------------------------------------------------EGEVSADEEGFENLWATASTFIVLFLLSLFYSTTVTLFKVK
----------------------------------------YLAMTPLIPQSKDENSDDYTTFDDVGSLWTTLSTFVALFILTLLYSGIVTFIKVK
-------------------------------------------------ELQLEESCAEAQDGELDGLWTTITIFITLFLLSVCYSATVTFFKVKWIFSSVVDLKQTIIPDYRNMIGQGA
-------------------------------------------------ELQLEESCAEAQDGELDGLWTTITIFITLFLLSVCYSATITFFKVKWIFSSVVDLKQTIVPDYRNMIRQGA
-------------------------------------------------ELQLEESCAEAQDGELDGLWTTITIFITLFLLSVCYSATVTFFKVKWIFSSVVDLKQTIIPDYRNMIGQGA
-----------------------------------GSCSVADWQMPPPYVVLDLPQETLEEETPGANLWPTTITFLTLFLLSLFYSTALTVTSVRGPSGNREGPQY
GSCCVADWQMPPPYVVLDLPQETLEEETPGANLWPTTITFLTLFLLSLFYSTALTVTSVRGPSGKREGPQYhlIgA2  
hsIgA1-2 
hlIgE
hsIgE
-----------------------------------
-----------------------------------------DWQMPPPYVVLDLPQETLEEETPGANLWPTTITFLTLFLLSLFYSTALTVTSVRGPSGKREGPQY
GLAGGSAQSQRAPDRVLCHSGQQQGLPRAAGGSVPHPRCHCGAGRADWPGPPELDVCVEEAEGEAPWTWTGLCIFAALFLLSVSYSAALTLLMVQRFLSATRQGRPQTSLDYTNVLQPHA
----------------------------------------------------ELDVCVEEAEGEAPWTWTGLCIFAALFLLSVSYSAALTLLMVQRFLSATRQGRPQTSLDYTNVLQPHA
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 The exact mechanism of the initiation of BCR signaling 
is still a matter of speculations and several models have been 
proposed. According to the most accepted model, a signal is 
initiated upon oligomerisation of two isolated BCR com-
plexes through engagement by antigen (crosslinking of the 
receptors). Alternative models explain the initiation of sig-
naling by a conformational change within the receptor upon 
antigen encounter, or by the selective shuttling of engaged 
receptors into lipid rafts which are specific domains of the 
plasma membrane, optimised for the initiation of signals 
(reviewed in [11, 12]). 
 Upon binding to antigen, the receptor is linked to the 
cytoskeleton and rapidly internalised. However, internalisa-
tion is not necessary for signal transduction and B cell acti-
vation. Rather, the route of internalisation is crucial for anti-
gen processing and subsequent presentation to T cells to ini-
tiate an immune response [13]. 
 Despite different opinions [11, 12], it is largely accepted 
that the different Ig isotypes initiate signaling in a similar 
way. Differences in the amino acid composition of the 
transmembrane domains and cytoplasmic tails of the differ-
ent isotypes may, however, account for the recruitment of 
distinct signaling components in addition to Ig- and Ig-
 [11]. 
 During development in the bone marrow, mIg is re-
stricted to the IgM isotype, but as soon as the B cell leaves 
the bone marrow to populate peripheral lymphoid organs like 
spleen, lymph nodes, or intestinal mucosal tissue, it starts to 
express a second isotype on the surface, IgD. From this time 
point onwards these cells are called mature naïve B cells. On 
antigen contact, linked with T cell help through engagement 
of the T cell receptor, mature B cells are able to diversify the 
constant Ig regions by class switch recombination (CSR). In 
CSR the isotype of the Ig is changed without affecting the 
antigenic specificity by a deletion mechanism that recom-
bines a specific region 5' of the IgM constant region gene 
(switch region) with a homologous switch region 5' of an-
other constant region gene, thereby excising the interceding 
DNA. The recombination events generate new B cells pro-
ducing Ig isotypes belonging to the ,  or  class depending 
on the switched region. 
THE MECHANISM OF CLASS SWITCH RECOMBI-
NATION 
 After the induction of switch recombination a gene seg-
ment between two switch regions is removed, causing a dou-
ble strand break in the S regions, followed by repair (Fig. 2). 
These results in a new, hybrid switch region which is made 
up of the 5’ and the 3’ end of the S regions involved and 
which can be used again in a further switch recombination 
process. Switch recombination is dependent on transcription 
starting from a promoter site upstream of the S region. The 
transcript includes a non-functional exon (I exon), located 5’ 
of the S region. Successful switch recombination apparently 
depends on processing (i.e. splicing) of this transcript. 
Switch recombination is normally dependent on the close 
interaction with helper T-cells (Th cells) [14, 15]. Upon 
priming, Th-cells cells secrete cytokines like interleukin (IL)-
4, IL-13, interferon (INF)-  or Transforming Growth Factor 
(TGF)- [16]. The cytokines initiate or suppress transcrip-
tion from the promoters upstream of I exons therewith de-
termining the isotype that will be involved in switch recom-
bination. Priming of T-cells is not dependent on antigen 
presentation by B cells, switch recombination, however, is 
dependent on class II MHC expression by B cells [17]. 
Primed T cells express the CD40 ligand which binds and 
crosslinks the CD40 antigen on B cells [18]. This interaction, 
and others like the CD28-CD80/CD86 interaction [19], take 
place in the germinal centre [20-22] and are essential for the 
initiation of the switch recombination. Switch to IgE is in-
duced by IL-4 and IL-13 [23], and inhibited by IFN- [24]. 
Interaction of IL-4 with its receptor causes the activation of 
STAT6 and its translocation to the nucleus, where it binds to 
an IL-4-responsive element in the promoter region 5’ of the  
gene [25]. 
 Switch to IgE in vitro is also induced by lipopolysaccha-
rides (LPS) and IL-4 [14]. Recently, the receptor for LPS on 
 
Fig. (2). The VDJ re-arranged segments are followed by eight (mouse) or nine (human) constant regions of different isotypes. Each isotype 
(except IgD) consists of a switch region, regulated by an upstream promoter/I exon region. So far identified transcription factor binding sites 
are indicated for the promoter region of the  region. 
 
μ δ γ3 γ1 α1 γ2 γ4 ε α2

μ δ γ3 γ1 γ2b γ2a ε α
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B cells has been identified. It is the Toll-like receptor-4 
(Tlr4), which belongs to the IL-1-receptor/Toll-like receptor 
family [26]. CD40 and the Toll receptor family share a sig-
nal transduction pathway: they both induce the translocation 
to the nucleus of NFB [27]. Among other activities NFB 
can cooperate with STAT6 in the induction of germ line ep-
silon transcripts [28]. 
 In conclusion, switch recombination depends on direct T-
B cell interaction, the type of cytokine produced, transcrip-
tional activation, RNA processing, DNA excision, and effi-
cient DNA repair. The effects of some of these factors on the 
switch to IgE are well documented like the effect of cytoki-
nes; others are poorly or not studied at all (RNA processing, 
DNA excision, and efficient repair). Yet, they are of essen-
tial importance in the number of cells that will be recruited 
in an IgE-mediated immune response. 
THE BIOLOGY OF THE IgE ANTIGEN RECEPTOR 
AND ITS IMPACT ON IgE SYNTHESIS 
 From an evolutionary point of view, IgE is conserved and 
can be found in all mammals, including monotremata [29]. It 
therefore originated at least 160 million years ago, possibly 
even more than 300 million years ago [30], from a gene du-
plication of IgY, in which the anaphylactic and opsonic ac-
tivities of IgY were separated, giving rise to IgE and IgG, 
respectively [31]. Apparently, in an evolutionary sense, ana-
phylactic defence mechanisms are needed, but can be of po-
tentially high risk for the organism. The segregation of ana-
phylactic and opsonic activities in separate genes allowed 
principally a tighter and more specific control of both im-
mune responses. 
 Membrane IgE (mIgE), in contrast to its soluble form, 
contains three additional structural features encoded by exon 
M1 and M2, namely the EMPD (extracellular membrane-
proximal domain) domain, the transmembrane domain an-
choring the receptor and being involved in the assembly with 
the CD79/ sheath [32, 33] and the cytoplasmic domain. 
The EMPD regions of the five isotypes differ in length and 
amino acid composition, e.g. the two functional forms of 
human EMPD, namely short and long are composed of 14 and 
66 amino acids [34-36], respectively. According to a study 
of Poggianella et al., carried out in the mature murine B-cell 
line A20, the presence of the EMPD region is of critical im-
portance for mobilizing intracellular Ca
2+
, with the EMPD’s 
length apparently being the ‘sensor’ of caspase independent 
apoptosis sensitivity. A similar phenomenon of proliferation 
inhibition has been reported in murine WEHI-231 cells 
transfected with the shorter human version of mIgE [37]. 
This study also showed that the rate of transport by which 
the two forms are brought to the cell surface as well as the 
association with CD79-a, and the kinetics of protein tyrosine 
phosphorylation in response to receptor cross-linking, differ 
between the short and the long version. Thus, the lenght of 
the EMPD region might have an essential function in shap-
ing the repertoire of mIgE
+
 plasmablasts selected towards the 
long lived plasma cell fate. 
 The fourth constant exon of IgE, which is located 5-
prime of the transmembrane and the cytoplasmic exons, is a 
composite exon: it contains an internal splice donor site, 
which is used when mRNA for membrane bound Ig is gener-
ated. It is also followed by an “internal” polyadenylation-
addition site that is used when mRNA for secreted Ig is 
made. A 3’ “external” polyadenylation-addition site is found 
downstream of the membrane exon. Except for the “internal” 
and the “external” polyadenylation signals of IgE, the con-
sensus sequence AATAAA is used. However, the  mem-
brane locus uses three cryptic “external” polyadenylation 
signals. These signals (AGTAAA, AAGAAA and AT-
TAAA) are in considerable disagreement with the consensus 
sequence [38]. The ratio of transcripts for the secreted and 
the membrane form of immunoglobulin reflects the usage of 
either polyadenylation signal. The choice depends normally 
on the developmental stage of the B lymphocyte. Therefore, 
the production of the two types of mRNA are determined by 
alternative splicing or rather, alternative polyadenylation 
[39]. The ratio between the amount of secreted versus mem-
brane-bound Ig that is produced by a single cell is therefore 
determined by the efficiency with which the internal or ex-
ternal polyadenylation sites are used and by the stability of 
the resulting mRNA’s. 
 Our data [38] unambiguously show that a fundamental 
difference between IgE and other immunoglobulins lies in 
the pattern of expression of the mRNA for the secreted and 
membrane form. Responsible for this difference is poor ex-
pression of the mRNA coding for the membrane form of 
IgE. Deletion of the "internal" polyadenylation signal results 
in a shift towards the expression of the mRNA for the mem-
brane form of IgE, which indicates that the "internal" poly-
adenylation signal is preferentially used. It also shows that 
the mRNA for the membrane form is not particularly liable 
to degradation. The exchange of the 3'UTR of the  HC gene 
with that of the μ HC gene also induces a shift towards the 
expression of mRNA coding for the membrane form, indi-
cating poor processing of the mRNA for the membrane form 
derived from the altered polyadenylation signals in the 
3'UTR of the  HC gene. 
 We conclude that low mIgE expression in human and in 
mouse is caused by a poor processing of the pre-mRNA of 
m due to deviant polyadenylation signal sequences. This 
distinct mechanism appears to set a high transcriptional 
threshold for IgE expression. Because expression of the 
membrane form of IgE is necessary for the survival or re-
cruitment of IgE-secreting cells, low expression of the 
mRNA for mIgE most likely limits the number of IgE-
secreting cells and thereby limits the magnitude of an IgE-
mediated immune response. 
ANIMAL MODELS 
 A step forward in understanding the role of mIgs was 
achieved with two mouse lines with mutations in the  heavy 
chain gene. In the first mouse line, the intracellular domain 
of IgE was removed except for three amino acids (Lys, Val, 
Lys) (KVKtail line). The cytoplasmic domain of IgE in 
these mice is the same as that of mIgM and mIgD. In the 
second mouse line both the intracellular and transmembrane 
domains of IgE (M1M2 line) are lacking [6, 40] (Fig. 3). In 
serum of M1M2 mice IgE is reduced to less than 10% of 
normal mice, while serum of KVK tail mice show a reduc-
tion of 50%, reflecting a serious impairment of the IgE-
mediated immune response. Class switch to IgE was not im-
paired by the targeting event. Upon stimulation of isolated 
spleen cells of wild type, M1M2 and KVKtail mice with 
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LPS and IL-4 in vitro [14, 41, 42], concentrations of IgE and 
IgG1 in the culture supernatants were comparable in wild 
type and mutant mice. These results imply that the reduced 
IgE titres found in both mutant lines are solely a reflection of 
the loss of biological activities associated with the trans-
membrane and cytoplasmic domains of IgE. 
 If the membrane domains are a prerequisite to recruit 
cells for the production of secreted IgE, how can we explain 
that residual serum IgE is present in M1M2 mice? Interest-
ingly, the isotype switch to IgE induced by IL-4 and the 
polyclonal B-cell activator LPS is not impaired in M1M2 
mice. The LPS-receptor Tlr4 belongs to the Toll-like recep-
tor family, a conserved family of proteins that is involved in 
innate immunity. It uses the same signal transduction path-
way as CD40 to achieve a change in nuclear metabolism: 
NFB is activated and translocated to the nucleus. It is con-
ceivable that any activation which involves NFB and 
STAT6 can induce switch recombination to IgE, even inde-
pendent of the anatomical site. The residual IgE in M1M2 
mice could therefore stem from a polyclonal activation in-
volving NFB in the presence of sufficient amounts of IL-4. 
A real-life example of such a scenario could be the encounter 
with the helminth Nippostrongylus brasiliensis. N. brasilien-
sis induces a robust IgG1 and IgE production, both through a 
dominant activation of Th2 cells, and a strong, T-cell inde-
pendent activation of B cells [43, 44]. We measured the se-
rum levels of IgE after infestation with N. brasiliensis: wild 
type mice showed a 50 fold increase in serum levels, as did 
the mutant mice, however, these mice started with a much 
lower serum IgE titer. Following secondary infestation, 11 
weeks after the first challenge with N. brasiliensis, a strong 
and fast IgE-response was seen in the wild type mice, indica-
tive of a memory response. The IgE response in the 
KVKtail was also substantial, but reached only 55% of the 
wild type response, and in M1M2 mice IgE reached meas-
urable levels. Interestingly, when the IgE titres of control 
and mutant mouse lines are compared to the titres in infested 
animals, a rather constant ratio is observed (20: 10: 1, com-
paring wild type to KVKtail and M1M2, respectively). 
The results indicate that the IgE response to N. brasiliensis 
also needs a specific interaction with the IgE antigen recep-
tor complex on the B cell, accompanied by strong Th2 helper 
activity. The measurable level of IgE secretion in the 
M1M2 mice after the secondary challenge with N. brasil-
iensis can therefore be explained by an even stronger Th2 
memory response together with a direct stimulation of B 
cells, leading to the activation of NFB, switch recombina-
tion and IgE secretion, similar to the response to LPS + IL-4 
obtained in vitro. An alternative explanation would be the 
relatively rare occurrence of an indirect isotype switch from 
IgM to IgE via IgG1. The last pathway would rely on the 
control function of mIgG1, and therefore be mIgE independ-
ent. 
 Our data clearly show that the transmembrane domain of 
IgE is indispensable for a T-cell-dependent IgE-mediated 
immune response, and that the cytoplasmic tail not only de-
termines the absolute amount of IgE produced, but also the 
quality of the antibodies. 
 Two hypotheses can be brought forward. The first im-
plies that signals generated via membrane-bound Ig are 
needed at all times, not only for the maturation process, but 
also for the expansion of antigen-specific cells. The second 
hypothesis postulates that antigen presentation to T-helper 
cells is necessary at all times during an antibody response 
and that the antigen receptor is the only device for an effec-
tive antigen presentation. The hypotheses are not necessarily 
mutually exclusive. All Ig classes can associate with the Ig-
/Ig- heterodimer [45], the signal-transducing unit of the 
B-cell receptor. Recent experiments have shown that an in-
tact antigen receptor on B cells is required for their survival 
[46]. It is not clear from these experiments which function 
the antigen receptor performs: interactions with external 
 
Fig. (3). In the KVKtail line the intracellular domain of IgE was removed except for three amino acids (Lys, Val, Lys). The cytoplasmic 
domain of IgE in these mice is the same as that of mIgM and mIgD. In the M1M2 line both the intracellular and transmembrane domains of 
IgE are lacking. Arrows indicate the ability of the different receptors to support signal transduction which is lacking in M1M2 mutants un-
able to produce membrane-bound IgE. 
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ligands, maintenance of a tonic signal generated by the mere 
presence of the receptor in the membrane, or capture of anti-
gen. Both Ig-/Ig- sheath and the cytoplasmic tail of mIg 
[47] have been implied in guiding receptor-bound antigen to 
the antigen-processing compartments. Key residues for in-
ternalization are present in the tails in the form of an YxxI/M 
motif. Because IgG can be expressed at the surface of a B 
cell without the Ig-/Ig- sheath [45] and in this condition is 
devoid of signaling capacity, the IgG receptor would serve as 
an efficient antigen-capturing unit, without eliciting a direct 
cellular response. This condition could be a prerequisite for 
processes that are highly dependent on T-B cell interactions 
like somatic mutation and affinity maturation and the genera-
tion of memory cells, but also processes like the rescue from 
apoptosis and the induction of plasma cells. These considera-
tions predict that the results we obtained in the KVKtail 
and M1M2 lines can be extended to the IgG isotypes, and 
perhaps to IgA. Indeed, Kaisho et al. [48] reached matching 
conclusions, studying mice carrying similar mutations in the 
1 gene. The phenotype of the mIgG mutants is, however, 
more prominent. A possible explanation is that IgE expres-
sion requires the Ig-/Ig- sheath, which may partly com-
pensate for the loss of the IgE tail. 
 Recently, Waisman et al. [49] described a mouse strain in 
which B cell development relies either on the expression of 
membrane-bound immunoglobulin 1 or μ heavy chains. 
Progenitor cells expressing 1 chains from the beginning 
generate a peripheral B cell compartment of normal size with 
all subsets, but a partial block is seen at the pro– to pre–B 
cell transition. Accordingly, 1-driven B cell development is 
disfavoured in competition with developing B cells express-
ing a wild-type IgH locus. However, the mutant B cells dis-
play a long half-life and accumulate in the mature B cell 
compartment, and even if partial truncation of the Ig- cyto-
plasmic tail compromises their development, it does not af-
fect their maintenance, as it does in WT cells. 
 As the BCR acquires a new signaling module in terms of 
the cytoplasmic tail and, perhaps, other parts of the newly 
expressed IgH chain upon isotype switching, it was of inter-
est to ask whether the cytoplasmic tails of the Ig-/Ig- het-
erodimer, which mediate signal transduction through IgM 
and IgD BCRs, are required for the maintenance of B cells 
expressing an IgG1 BCR. Indeed, it was shown previously 
that the Ig- cytoplasmic tail is required for the survival of 
mature B cells in WT mice [50, 51]. Waisman et al. demon-
strated that, in contrast to this result, the partial truncation of 
the Ig- cytoplasmic tail does not impede the survival of B 
cells expressing an IgG1 BCR. The simplest interpretation of 
this finding is that, in accordance with the considerations 
above, the 1 chain indeed delivers a survival signal to the 
cells, and that this signal contributes to the longevity of 
memory B cells expressing class-switched BCRs. 
 An interesting question for future investigations will be 
the analysis of a mouse strain that exclusively expresses IgE 
as unique isotype class. With the additional knowledge that 
the cytoplasmic tail of mIgE binds a protein (HAX1), which 
might commit an anti-apoptotic signal transduction [52], one 
could speculate that anti-apoptotic signaling might enhance 
the release of self-reactive B cells in this mouse strain. The 
fact that an anti apoptotic protein, with respect to its cyto-
plasmic binding motif, seems to bind exclusively mIgE but 
not the other isotypes, underlines once again the unique posi-
tion of IgE among all Ig isotypes. 
SYSTEMIC THERAPEUTIC IMPLICATIONS BY 
BLOCKING mIgE SIGNALING 
 In today´s way of thinking, the B cell binds the antigen 
via its receptor, which transduces the first signal into the cell 
via activation of tyrosine kinases such as syk and lyn (re-
viewed in [11]). The receptor-antigen complex is then inter-
nalized, the antigen processed, and displayed as peptide 
MHC II complex on the B cell surface. Antigen binding to 
the B cell also stimulates expression of the co-stimulatory 
molecules B7-1 and B7-2. If T helper cells expressing recep-
tors able to recognize the co-receptor - peptide-MHC com-
plexes exist, then the ensuing T cell B cell interaction pro-
vides the second signals in the form of a CD40-ligand CD40 
interaction and the release of stimulatory cytokines such as 
IL-4 and IL-5 or IFN-. In this framework, antigen stimula-
tion of B cells in the absence of T cell help leads to toler-
ance, while stimulation in the presence of antigen specific T 
cell help leads to proliferation and differentiation. In other 
words, stimulation of B cells via the antigen receptor without 
appropriate T-cell help normally leads to apoptosis [53]. 
 Can these data be adapted for the induction of tolerance 
and/or anergy of a class-switched mIgE bearing B cell popu-
lation by using anti IgE antibodies? Two scenarios for the 
mode of action of a humanized anti IgE antibody, if consid-
ered by the immune system as self antigen unable to recruit 
T cell help, would be thinkable. First, as shown by self react-
ing immature B cells, cross linking of the mIgE receptor 
without further T cell support should directly induce apopto-
sis. Second, as shown during the induction of peripheral tol-
erance of mature B cells in answer to monovalent (self) anti-
gen, receptor blockage of mIgE by, for example, a Fab-
fragment should result in an anergic state of the mIgE popu-
lation. In contrast to normal mature B cells, which have a 
half life of 4 to 5 weeks, anergic B cells were found to last 
for only 3 to 4 days [54]. Nevertheless the fate of these aner-
gic B cells finally turns out to be cell death [55]. 
 This simplified scenario is restricted to a very special 
lymphocyte elimination process. However, T and B lympho-
cytes undergo apoptosis in many instances in their develop-
ment, homeostasis, and activation. Lymphocytes die during 
development if they fail to locate or compete for cytokines, 
fail to properly rearrange an antigen receptor, fail to be posi-
tively selected, or are negatively selected. In the periphery, 
resting lymphocytes are eliminated from, or unable to enter 
the long-lived re-circulating pool if they fail to locate or 
compete extrinsic signals. For example B cells that bind and 
present antigenic peptides on MHC II to T cells can also 
undergo receptor induced apoptosis. Germinal centre B cells 
that lose affinity for selecting antigen or gain specificities for 
self antigens are also eliminated. Furthermore, lymphocytes 
that fail to become memory cells after antigen clearance are 
also eliminated (reviewed in [56]). 
 Our knowledge about the regulation of the expression of 
membrane-bound IgE is at best limited. Unfortunately, a 
similar statement can be made regarding the function of the 
transmembrane and the cytoplasmic domain of IgE. We, 
however, know that the production of IgE is tightly regulated 
on the level of DNA recombination (switch), transcription, 
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and RNA processing. Transgenic mouse experiments [6] 
clearly showed that the transmembrane domain of mIgE is 
indispensable for T-cell dependent IgE secretion and that the 
cytoplasmic domain not only determines the absolute 
amount of IgE produced, but also influences the quality of 
the immunoglobulins. Thus, if mIgE seems to be the prereq-
uisite for the later production of secreted IgE, targeting mIgE 
bearing B cells with anti-mIgE specific antibodies could be a 
therapeutic option. A possible target domain is represented 
by the extra membrane proximal domain (EMPD), coded as 
part of the transmembrane domain M1 (Fig. 4). The EMPD 
could be used as target sequence for generating anti mIgE 
antibodies with the capacity to inhibit IgE synthesis. First 
results with this approach were published by Chen et al., 
which examined the ability of an anti-spacer specific anti-
body on targeting and lysing mIgE expressing B cells [57]. 
Thus, the pharmacological targets of this approach are mem-
ory B cells involved in secondary immune responses. 
mIgE
 
Fig. (4). A possible target domain is represented by the extra mem-
brane proximal domain (EMPD), coded as part of the transmem-
brane domain exon M1. The EMPD could be used as target se-
quence for generating anti mIgE antibodies with the capacity to 
inhibit IgE synthesis. 
 Summarizing, if anti-mIgE antibodies indeed inhibit or 
down-regulate IgE synthesis in vivo, these antibodies may be 
used to treat allergic patients with very high IgE levels. The 
advantage of this second generation anti-IgE therapy would 
be the ability of inhibiting IgE secretion before secreted IgE 
production starts. 
CONCLUSIONS 
 The BCR plays a central role in almost all processes 
along the developmental pathway of B cells, i.e. the genera-
tion, maturation, survival, and activation of B cells. Obvi-
ously, between Ig subclasses, there should be no differences 
in the transduction of signals regulating the central features 
of the immune system such as the control of allelic exclu-
sion, early cellular transitions and in the function of the 
membrane-bound immunoglobulin as a receptor for antigen 
capture and presentation. However, recent experiments indi-
cate that, apart from the signal transduction pathways via Ig-
/Ig-  cytoplasmic tails, the mIgs itself have the capacity to 
engage in the signal transduction pathway, influencing the 
quantity and quality of the immune response. 
 The synthesis of sIgE by plasma cells is comparable to 
that of other Ig classes. However, alternative polyadenyla-
tion of the mIgE transcript [38], together with a negative 
feed-back regulatory mechanism [4], the low half-life of 
sIgE [3], and the low frequency of switch recombination [2, 
5] leads to a more than 1000-fold lower IgE than IgG1 serum 
level in the mouse. This is in agreement with the notion that 
IgE is needed for immune defence, but only localised and at 
very low level. It is, however, not known whether the func-
tional recruitment of B cells after a switch to IgE is a sto-
chastic process, selecting only those cells that managed a 
sufficient expression of mIgE, or whether other factors, only 
expressed in a fraction of -switched B cells, facilitate mIgE 
expression and recruitment. 
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